As of May 26
| -0.60 / -3.79%|
The 10 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 15.50, with a high estimate of 21.00 and a low estimate of 9.00. The median estimate represents a +1.64% increase from the last price of 15.25.
The current consensus among 11 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.